Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
780 7 |
Ultima descărcare din IBN: 2024-04-11 20:31 |
SM ISO690:2012 NICULISEAN, Elvira, SOFRONI, Larisa, CERNÎI, Anatolie. Stadiul evolutiv al cancerului mamar şi expresia receptorilor Her2. In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2007, nr. 4(13), pp. 228-230. ISSN 1857-0011. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale | ||||||
Numărul 4(13) / 2007 / ISSN 1857-0011 | ||||||
|
||||||
Pag. 228-230 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Expresia receptorilor factorului epidermal de creştere HER2 s-a cercetat imunohistochimic în carcinoamele mamare ale 197 de paciente şi a fost analizat nivelul expresiei HER2 în funcţie de stadiul evolutiv al tumorii. S-a demonstrat că tumorile HER2 negative predomină în stadiile precoce ale cancerului mamar. |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-11428</cfResPublId> <cfResPublDate>2007-07-03</cfResPublDate> <cfVol>13</cfVol> <cfIssue>4</cfIssue> <cfStartPage>228</cfStartPage> <cfISSN>1857-0011</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/11428</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Stadiul evolutiv al cancerului mamar şi expresia receptorilor Her2</cfTitle> <cfAbstr cfLangCode='RO' cfTrans='o'>Expresia receptorilor factorului epidermal de creştere HER2 s-a cercetat imunohistochimic în carcinoamele mamare ale 197 de paciente şi a fost analizat nivelul expresiei HER2 în funcţie de stadiul evolutiv al tumorii. S-a demonstrat că tumorile HER2 negative predomină în stadiile precoce ale cancerului mamar.</cfAbstr> <cfAbstr cfLangCode='EN' cfTrans='o'>The expression of the epidermal growth factor HER2 was studied imunohistochemically for breast cancer in 197 patients. It was analyzed the level of HER2 expression according to the stage of tumours. It was shown that the HER2 negative tumours prevale in the early stages of mammary carcinomas.</cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2007-07-03T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2007-07-03T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-19059</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2007-07-03T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-11785</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2007-07-03T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-11688</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2007-07-03T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-19059</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-19059-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2007-07-03T24:00:00</cfStartDate> <cfFamilyNames>Niculisean</cfFamilyNames> <cfFirstNames>Elvira</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-11785</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11785-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2007-07-03T24:00:00</cfStartDate> <cfFamilyNames>Софрони</cfFamilyNames> <cfFirstNames>Л.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-11688</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11688-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2007-07-03T24:00:00</cfStartDate> <cfFamilyNames>Черный</cfFamilyNames> <cfFirstNames>Анатолие</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>